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P2X1 receptor subunits assemble in the ER of Xenopus
oocytes to homotrimers that appear as ATP-gated cation
channels at the cell surface. Here we address the extent
to which N-glycosylation contributes to assembly, sur-
face appearance, and ligand recognition of P2X1 recep-
tors. SDS-polyacrylamide gel electrophoresis (PAGE)
analysis of glycan minus mutants carrying Gln instead
of Asn at five individual NXT/S sequons reveals that
Asn284 remains unused because of a proline in the 14
position. The four other sites (Asn153, Asn184, Asn210, and
Asn300) carry N-glycans, but solely Asn300 located only
eight residues upstream of the predicted reentry loop of
P2X1 acquires complex-type carbohydrates. Like parent
P2X1, glycan minus mutants migrate as homotrimers
when resolved by blue native PAGE. Recording of ATP-
gated currents reveals that elimination of Asn153 or
Asn210 diminishes or increases functional expression
levels, respectively. In addition, elimination of Asn210
causes a 3-fold reduction of the potency for ATP. If three
or all four N-glycosylation sites are simultaneously elim-
inated, formation of P2X1 receptors is severely impaired
or abolished, respectively. We conclude that at least one
N-glycan per subunit of either position is absolutely
required for the formation of P2X1 receptors and that
individual N-glycans possess marked positional effects
on expression levels (Asn154, Asn210) and ATP potency
(Asn210).
The P2X receptor family of ligand-gated cation channels
currently comprises seven isoforms (P2X1–P2X7) that are prod-
ucts of seven distinct genes (1–8). The encoded P2X polypep-
tides bear 36–48% sequence homology. All of the recombinant
P2X receptor subunits form functional homomeric complexes
when synthesized in heterologous cells. Both biochemical (9)
and electrophysiological analyses (10, 11) suggest that trimers
represent an essential structural element of P2X receptors,
although it must be noted that data consistent with a tetramer
have been also obtained (12). P2X receptors open within milli-
seconds an intrinsic pore nonselectively permeable for small
cations when activated by extracellular ATP (for reviews, see
Refs. 13–17). During prolonged activation, several P2X recep-
tor channels develop permeability also to rather large cations
such as organic dyes (18, 19).
Like virtually all membrane proteins, P2X receptors are
glycoproteins. A multitude of functional aspects of oligosaccha-
rides in glycoproteins have been described (for reviews, see
Refs. 20 and 21), including influence on topogenesis (22), aid of
proper protein folding (chaperone function) (23), quality control
in the secretory pathway (24), prevention of marginally stable
proteins from unfolding, as well as protein-protein interactions,
ligand binding (25), and intracellular trafficking (26). The role
of a particular N-glycan in a given protein, however, has been
found to be rather unpredictable and may comprise several of
the above mentioned functions, or it may have no known func-
tion at all and be completely dispensable.
The protein sequence of the rat P2X1 subunit shows five
putative N-glycosylation sites consisting of the NXT/S sequon
(where X denotes any amino acid except proline), which are all
located in the predicted P2X1 ectodomain (1). We have recently
shown that four of these five putative N-glycosylation sites of
the rat P2X1 subunit are used in Xenopus oocytes (9). Notably,
only one of the four N-glycans acquires Endo H1 resistance en
route to the plasma membrane. Since P2X1 subunits assemble
rapidly and quantitatively to noncovalently linked homotrim-
ers soon after synthesis while still in the ER, it seems likely
that the three-dimensional structure of the fully assembled and
properly folded P2X1 receptor sterically hindered the access of
particular Golgi enzymes to three of the four N-glycans. Hence,
we considered that one or several of these inaccessible N-
glycans play a role in stabilizing these interactions or even
directly participate in subunit interactions in a lectin-like
manner.
To examine whether N-glycans are important for P2X sub-
unit assembly, surface expression, or ligand recognition, we
eliminated N-glycosylation sites by site-directed mutagenesis
and analyzed the oligomerization and ATP-gated currents of
the corresponding receptors in Xenopus oocytes by SDS-PAGE,
blue native PAGE, and two-electrode voltage clamp measure-
ments, respectively. An additional aim of the study was to
examine the effect of N-glycans on the migration of P2X recep-
tor complexes in the blue native PAGE system. Our results
show that any two out of the four naturally occurring N-glycans
are sufficient for robust functional expression of P2X1 receptors
at the cell surface and that the N-glycan in position 210 con-
tributes to ATP potency.
EXPERIMENTAL PROCEDURES
cDNA Constructs—The construction of the His-P2X1 plasmid encod-
ing the rat P2X1 subunit with an N-terminal hexahistidyl tag has been
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described previously (9). His-P2X1 mutants lacking one or several con-
sensus sequences for N-glycosylation were generated by changing the
Asn of existing NXS/T codons to Gln using a commercially available kit
(QuikChangeTM mutagenesis kit from Stratagene). The resulting His-
P2X1 mutants were named DN1–DN5 (in sequence order) for single
mutants (Fig. 1), DN12, DN13, DN15, DN23, DN25, and DN35 for double
mutants, DN123 and DN235 for triple mutants, and DN1235 for the
quadruple mutant lacking all N-glycosylation sites. All mutations were
verified by dideoxynucleotide sequencing (27).
cRNA Synthesis—Capped cRNAs were synthesized from EcoRI-lin-
earized templates with SP6 RNA polymerase (Amersham Pharmacia
Biotech), purified by Sepharose chromatography and phenol-chloroform
extraction, and dissolved in 5 mM Tris/HCl, pH 7.2, at 0.5 mg/ml, using
the optical density reading at 260 nm for quantitation (OD 1.0 5 40
mg/ml).
Injection and Maintenance of Xenopus oocytes—Xenopus laevis fe-
males received from South Africa were anesthetized with MS222 (tric-
aine) for surgical removal of ovaries. After collagenase treatment (28)
defolliculated stage V or VI oocytes were manually selected and injected
with 50-nl aliquots of cRNAs. Injected oocytes were kept in parallel with
noninjected controls at 19 °C in sterile oocyte Ringer’s solution (ORi: 90
mM NaCl, 1 mM KCl, 1 mM CaCl2, 1 mM MgCl2, and 10 mM Hepes, pH
7.4) supplemented with 50 mg/ml of gentamycin.
Radioactive Labeling of Oocytes and Protein Purification—cRNA-
injected oocytes and noninjected controls were metabolically labeled by
overnight incubation with L-[35S]methionine (.40 TBq/mmol, Amer-
sham Pharmacia Biotech) at about 100 MBq/ml (0.4 MBq per oocyte) in
ORi at 19 °C and then chased as indicated. The His-P2X1 receptor and
its mutants were purified by Ni21-NTA-agarose (Qiagen) chromatogra-
phy from digitonin (1.0%) extracts of oocytes as detailed previously (9).
Protein was released from the Ni21-NTA-agarose with nondenaturing
elution buffer consisting of 200 mM imidazole HCl, pH 6.8, and 1.0%
digitonin. Eluted proteins were kept at 0 °C until analyzed.
For selective labeling of His-P2X1 receptors at the plasma mem-
brane, oocytes injected with cRNA 3 days earlier were incubated with
125I-sulfosuccinimidyl-3-(4-hydroxyphenyl)proprionate (125I-sulfo-
SHPP), a membrane-impermeant derivative of the Bolton-Hunter rea-
gent (29) exactly as described previously (9). Proteins were purified
from digitonin extracts of the oocytes by Ni21-NTA-agarose chromatog-
raphy as above.
Blue Native PAGE and SDS-PAGE—Blue native PAGE (30, 31) was
carried out as described previously (9, 32, 33). Just before gel loading,
purified proteins were supplemented with blue native sample buffer to
final concentrations of 10% glycerol, 0.2% Serva blue G, and 20 mM
sodium 6-amino-n-caproate and applied onto polyacrylamide gradient
slab gels. Molecular mass markers (Combithek II™, Roche Molecular
Biochemicals) were run on both borders of the gel and were visualized
by Coomassie Blue staining. For SDS-PAGE, proteins were supple-
mented with SDS sample buffer containing DTT and electrophoresed in
parallel with 14C-labeled molecular mass markers (RainbowTM, Amer-
sham Pharmacia Biotech) on SDS-polyacrylamide gradient gels. When
indicated, samples were treated prior to SDS-PAGE with either Endo H
or PNGase F (New England Biolabs) in the presence of 1% octyl gluco-
side to diminish inactivation of PNGase F. Gels were fixed, dried, and
exposed at 280 °C to BioMax MR or MS film (Kodak) as appropriate. In
some experiments, radioactive bands were quantified with an image
analyzer (PhosphorImager 445 SI, Molecular Dynamics).
Two-electrode Voltage Clamp Measurements—Current responses
were measured by using the two-electrode voltage clamp technique on
oocytes injected with His-P2X1 cRNA 3 days earlier. The electrodes
contained 3 M KCl and had resistances of 0.5–2 MV. The superfusion
solution consisted of 90 mM NaCl, 1 mM KCl, 2 mM MgCl2, and 5 mM
Hepes/NaOH, pH 7.4. Calcium salts were omitted to avoid activation of
endogenous Ca21-dependent Cl2 channels. A fast and reproducible
solution exchange was achieved as described previously (9). Current
signals were elicited by ATP at 1-min intervals, low pass-filtered at 100
Hz, and sampled at 200 Hz using the Turbo TEC-05 amplifier (NPI
Electronics, Tamm, Germany). All measurements were performed at
room temperature (20–22 °C).
RESULTS
The P2X1 Polypeptide Carries Glycans at Asn
153, Asn184,
Asn210, Asn300, but Not at Asn284—The P2X1 cDNA has been
originally cloned from rat vas deferens, where the P2X1 recep-
tor plays a role in muscle contraction (1), which propels sperm
into the ejaculate (34). The P2X1 polypeptide chain is 399
amino acids long. For affinity purification after synthesis in
Xenopus oocytes, we tagged the rat P2X1 polypeptide at its
N-terminal end with six histidine residues, which had no effect
on ATP-induced currents (9). The His-P2X1 subunit can be
isolated from cRNA-injected and [35S]methionine-labeled oo-
cytes as a 57-kDa glycoprotein (Fig. 2A, lane 1) that carries four
N-glycans making up ;18% by mass of the protein (9). The
deduced amino acid sequence of the P2X1 subunit shows five
asparagines for possible N-linked glycosylation (NXT/S):
N153GT, N184FT, N210GT, N284LS, and N300GT. Replacement of
Asn153, Asn184, Asn210, and Asn300 by Gln, one at a time,
resulted in the synthesis of glycoproteins that had a 2–3 kDa
lower mass than the wild type P2X1 glycoprotein (Fig. 2A, lanes
2–4 and 7). Since 2–3 kDa corresponds to the mass of one
N-linked oligosaccharide side chain, this finding implies that
each of the replaced asparagines is occupied by an N-glycan in
the wild type P2X1 subunit. In contrast, replacement of Asn
284
by Gln had no effect on the mass (Fig. 2A, lane 5), indicating
that Asn284 of the wild type P2X1 subunit is the asparagine
that is not used as a glycosyl acceptor site.
The inability to glycosylate Asn284 of the N284LS sequon may
be attributed to the leucine residue in the X position, which has
been found to impair core glycosylation (35). Alternatively,
Pro287 immediately following the N284LS sequon might be re-
FIG. 1. Linear model of rat P2X1 showing approximate posi-
tions of N-glycosylation sequons and corresponding glycan mi-
nus mutants. N, cytoplasmic N terminus; M1 and M2, membrane
spanning segments; N1–N5, asparagine residues of NXT/S tripeptides
at position 153 (N1), 184 (N2), 210 (N3), 284 (N4), and 300 (N5). The 10
cysteine residues (S), which are conserved among all seven P2X iso-
forms and which are assumed to form five intramolecular disulfide
linkages, are also indicated; an additional conserved cysteine residue
(not shown) is located in M2.
FIG. 2. N-Glycosylation of His-P2X1 mutants each lacking one
out of five N-glycosylation sites. Oocytes injected with 23 ng of the
indicated cRNAs were metabolically labeled by overnight incubation
with [35S]methionine. After an additional 24-h chase interval, digitonin
extracts were prepared. Parent His-P2X1 and the various glycan minus
mutants were isolated by Ni21-NTA chromatography, eluted with non-
denaturing elution buffer, and then supplemented with SDS sample
buffer, 20 mM DTT (final concentration). Samples were incubated for 15
min at 37 °C in the absence (A) or for 2 h at 37 °C in the presence of
Endo H (B) or PNGase F, 1% octyl glucoside (C), and then analyzed by
SDS-PAGE (10% acrylamide) followed by autoradiography.
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sponsible, since proline inhibits core glycosylation not only at
the X, but also at the 14 position (36). Indeed, Asn284 was
efficiently used as a glycosyl acceptor site when alanine was
substituted for Pro287, as inferred from the reduced mobility of
the His-Ala287-P2X1 polypeptide, indicating the presence of an
additional (fifth) N-glycan (Fig. 2A, lane 6). The occupancy of
Asn284 by a glycan had no apparent effect on P2X1 receptor
function, as deduced from the magnitude and concentration
dependence of ATP-gated currents (results not shown). The
efficient glycosylation at Asn284 after elimination of Pro287
argues against a significant role of Leu285 for the inability to
glycosylate Asn284 of the parent P2X1 polypeptide.
Solely the Glycan at Asn300 Acquires Complex-type Carbohy-
drates—From the four N-glycans per P2X1 receptor subunit,
only one acquired Endo H resistance during transport to the
plasma membrane of Xenopus oocytes (9). This suggests that
processing by Golgi enzymes of three of the N-glycans is steri-
cally hindered, most likely as a result of folding and oligomer-
ization of the P2X1 chains. Fig. 2B shows that like the parent
His-P2X1 receptor (lane 1) all the P2X1 receptor mutants (lanes
2–6) except DN5 (lane 7) acquired Endo H-resistant carbohy-
drates. Since the P2X1 receptor mutant DN5 appears at the
plasma membrane (cf. Figs. 3–5), the absence of Endo H-resist-
ant carbohydrates can be directly conferred to the lack of the
sole N-glycan that can acquire complex-type carbohydrates
during transit of the Golgi apparatus. This indicates that the
glycan at Asn300 of the parent His-P2X1 receptor subunit is the
one accessible for complex glycosylation.
At Least One N-Glycan per Subunit at Either Position Is
Needed for P2X1 Receptor Formation—To examine whether the
elimination of a particular N-glycan affects the expression level
of functional P2X1 receptors, we recorded current responses to
30 mM ATP at 240 mV. This ATP concentration elicited differ-
ent yet maximum responses at the parent P2X1 receptor and all
receptor mutants, since activation with 100 mM ATP did not
result in a further increase of currents. Like the parent P2X1
receptor, also all receptor mutants lacking one N-glycan per
subunit exhibited large ATP-gated currents, indicating that no
particular N-glycan is essential for receptor function (Fig. 3).
There are, however, marked positional effects of the N-glycans.
While the glycans at N2 or N5 were without significant effect
on the expression level of functional receptors, elimination of
the glycan at N1 or N3 resulted in a 30% decrease or 70%
increase, respectively, of the current response (Fig. 3). Like-
wise, reduced currents were recorded from double mutants that
lacked N1 together with N2 or N5, whereas elimination of N3
consistently resulted in increased currents even when N1 was
simultaneously eliminated (Fig. 3). These findings suggest that
the glycans at N1 and N3 play opposing roles for the expression
level of functional P2X1 receptors.
Elimination of any three N-glycans did also not prevent P2X1
receptor formation, but the functional expression level de-
creased markedly to ,10% of that of the parent P2X1 receptor.
The currents were particularly low when the three acceptor
sites that were eliminated included N1 (Fig. 3). No ATP-in-
duced currents could be recorded from oocytes after removal of
all canonical N-glycosylation sites. Taken together, these re-
sults implicate that despite their marked positional effects,
only one N-glycan at any locus is required for the formation of
functional P2X1 receptors, and two such sites are sufficient for
robust functional expression.
Elimination of the Glycan at Asn210 Decreases ATP Potency—
Since N-glycans are bulky and can shield a large section of the
protein surface, we examined whether elimination of N-glycans
affects ATP potency. To this end, we recorded receptor currents
elicited by 0.3 and 30 mM ATP and determined the ratio of the
current responses at these two ATP concentrations. As appar-
ent from Fig. 4C, all the receptor mutants lacking N3 (Asn210)
showed a current ratio of 5–7% independent of simultaneous
elimination of additional N-glycosylation sites. In contrast, all
glycan minus receptor mutants that contained N-glycan N3
showed a ratio of 26–37% similar to the 32% for the parent
His-P2X1 receptor. Since N3 turned out to be crucial for the
reduced potency, concentration response curves for ATP of DN3
and parent His-P2X1 were recorded. Fitting the Hill equation
to the data for the parent His-P2X1 receptor yielded an EC50
value for ATP of 0.7 mM (Fig. 4D). In contrast, the glycan minus
FIG. 3. Comparison of maximum inward current responses
generated by parent P2X1 and glycan minus mutants. Oocytes
were injected with 23 ng of the indicated cRNAs. After 3 days at 19 °C,
currents were activated at a holding potential of 240 mV by 30 mM ATP,
which elicits maximum responses at parent His-P2X1 and each mu-
tants. Currents were normalized to the response of the parent His-P2X1
receptor. Data are given as means 6 S.E. from 20–48 oocytes per
column of two to six experiments with 6–10 oocytes per experimental
condition. Currents significantly different from that of parent His-P2X1
are denoted by asterisks (*, p , 0.05; **, p , 0.001).
FIG. 4. Comparison of ATP potency between parent His-P2X1
and glycan minus mutants. Inward current traces were recorded at
the indicated ATP concentrations and a holding potential 240 mV from
oocytes injected 3 days earlier with 23 ng of cRNA for parent His-P2X1
(A) or the glycan minus mutant DN3 (B). C, the ratio between currents
activated at 240 mV by 0.3 and 30 mM ATP was calculated as a measure
of the ATP potency at the various glycan minus mutants (n 5 5–6,
mean 6 S.E.). Note that all mutants lacking N-glycosylation site N3
exhibit a markedly decreased current ratio indicative of a reduced ATP
potency. D, ATP dose-response curve for parent His-P2X1 (f) and mu-
tant DN3 (l ). Currents were elicited by the respective ATP concentra-
tion in 1-min intervals. Continuous lines represent least squares fits of
the Hill equation to the data points, yielding EC50 values of 0.7 6 0.1 mM
(Hill coefficient of 1.1 6 0.1) and 2.1 6 0.2 mM (Hill coefficient of 1.3 6
0.1) for parent His-P2X1 and mutant DN3, respectively (n 5 6–7,
mean 6 S.E.).
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receptor mutant DN3 exhibited an EC50 value of 2.1 mM, i.e. a
3-fold reduced potency for ATP. The Hill coefficients (1.1 versus
1.3) were not significantly different.
P2X1 Glycan Minus Receptor Mutants Migrate as Homotri-
mers When Resolved by Blue Native PAGE—An additional aim
of the present study was to examine the influence of carbohy-
drates on P2X1 receptor assembly as assessed by blue native
PAGE analysis. Parent His-P2X1 subunits combine rapidly to
stable homotrimers that exit the ER (9), transit the Golgi
where complex glycosylation of N5 occurs (Fig. 2), and finally
appear at the plasma membrane. To visualize the plasma mem-
brane form of the His-P2X1 glycan minus receptor mutants, we
radioiodinated oocyte surface proteins with membrane imper-
meant 125I-sulfo-SHPP and then isolated the His-tagged pro-
teins by Ni21-NTA chromatography. When resolved by blue
native PAGE, the parent His-P2X1 receptor migrated at 250–
290 kDa (Fig. 5) as reported previously (9). Overall, elimination
of N-glycans resulted in a slight increase in electrophoretic
mobility, corresponding maximally to 20 kDa when two N-
glycans per subunit were lacking (Fig. 5A). Within the techni-
cal limits of receptor quantification by surface radioiodination,
all the receptor mutants lacking one N-glycan (Fig. 5A, lanes
3–6 and 8–11) and most of the mutants lacking two N-glycans
(lanes 12–14) were present at approximately the same density
at the plasma membrane as the parent His-P2X1 receptor. The
amount of receptor protein decreased markedly when the two
acceptor sites that were eliminated included N1 (Fig. 5A, lane
15) or when three N-glycans per subunit were eliminated (lane
16). We did not attempt to directly correlate radioiodinated
protein and current responses, because differences in the 50%
range resolvable by electrophysiological analysis cannot be re-
producible detected by surface radioiodination.
To display the oligomeric state of these receptor complexes,
we exposed the natively eluted His-P2X1 mutant receptors to
DTT in the presence of Coomassie Blue and sodium 6-amino-
n-caproate. This treatment causes a partial dissociation of the
parent His-P2X1 receptor to the monomer and dimer of appar-
ent masses similar to 80 and 170 kDa, respectively, indicating
that the nondenatured 250-kDa protein band must be a His-
P2X1 homotrimer (9). Likewise, also the His-P2X1 glycan mi-
nus receptor mutants lacking one or two N-glycans per subunit
dissociated into dimers and monomers when exposed to DTT
(Fig. 5B). Quantification of the bands by phosphor image anal-
ysis shows that the extent of dissociation induced by DTT is
virtually identical for the three N-glycan minus mutant recep-
tors. It should be noted that the dissociating effect of DTT does
not result from a cleavage of intersubunit disulfide linkages,
but from a perturbation of noncovalent subunit interactions.
Dissociation of P2X1 complexes into monomers could also be
produced by other denaturing additions such as urea or SDS,
which by themselves will not affect disulfide bonds (9). In
summary, receptor mutants lacking up to three N-glycans per
subunit exist in a homotrimeric state like the wild type P2X1
receptor. A mutant that lacked all four N-glycans could neither
be detected by two-electrode voltage clamp measurements nor
by Ni21 chelate chromatography followed by SDS-PAGE and
autoradiography.
DISCUSSION
Factors That Control N-Glycosylation of P2X1 Receptors—
The P2X1 receptor influences its own N-glycosylation at two
levels: (i) at the level of its primary sequence and (ii) the level
of its three-dimensional structure. First, the N284LS tripeptide
(N4) is not used as a site for N-glycosylation because of a
proline residue in the 14 position. Replacement by alanine
resulted in unimpaired N-glycosylation at this site. This obser-
vation agrees well with previous reports that the presence of
proline immediately following a sequon can inhibit core glyco-
sylation (36, 37). A sequon with a proline in 14 position is also
present on the P2X4 polypeptide, but not on the other P2X
isoforms. Second, from the four N-glycans that are cotransla-
tionally attached per P2X1 subunit, only that at Asn
300 (N5)
acquires complex-type carbohydrates during passage of the
Golgi apparatus, whereas the others remain in an Endo H-
sensitive form. This observation can best be reconciled with
constraints imposed by the three-dimensional structure of the
P2X1 receptor, which apparently restricts the access of individ-
ual N-glycans to processing by Golgi enzymes. We considered
that the restricted accessibility of the N-glycans results from a
lectin-like subunit interaction. However, present findings ex-
clude this possibility, since a P2X1 triple mutant devoid of the
three inaccessible N-glycans (DN123) acquired the same ho-
motrimeric configuration like the correctly glycosylated parent
P2X1 receptor and formed a functional P2X1 receptor at the
plasma membrane, although with low efficiency.
N-Glycans and Membrane Folding of P2X1—The two-dimen-
sional orientation of P2X subunits in the plasma membrane
has been predicted from hydropathy plots, usage of natural
N-glycosylation sites (9), and N-glycan scanning mutagenesis
studies (38, 39). The five putative N-glycosylation sites of the
P2X1 polypeptide are all located in the predicted ectodomain.
As noted previously, the demonstration that four of the five
natural sites are occupied by sugars confirms the membrane
topology deduced from hydropathy analysis, since N-glycosyla-
tion sites occur always on the extracellular portion of a protein.
Additional important information about membrane folding can
be deduced from the observation that Asn300 (N5) is not only
used, but also fully accessible to Golgi enzymes to acquire
complex-type carbohydrates. N5 is located only eight residues
FIG. 5. Glycan minus mutants migrate as trimers like parent
P2X1 when analyzed by blue native PAGE. Oocytes injected with
the indicated cRNA 3 days earlier were surface-labeled with membrane
impermeant 125I-sulfo-SHPP and extracted with digitonin. His-P2X1
and the His-tagged mutant proteins were then purified by Ni21-NTA
chromatography under nondenaturing conditions and resolved by
PAGE followed by autoradiography. A, proteins were resolved immedi-
ately after native elution by blue native PAGE (4–10% acrylamide
gradient gel). Shown are samples from two independent experiments. #,
contaminating protein not observed in other experiments (cf. lane 4); f,
front. B, proteins were analyzed after native elution either without
further treatment or after incubation with 100 mM DTT for the indi-
cated time period. Numbered arrows indicate positions of monomers,
dimers, and trimers.
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upstream of the conserved lipophilic domain (Fig. 6), which has
been postulated to constitute a reentry loop immediately before
M2 like the H5 domain of K1 channels and hence to contribute
to the pore (2). Using a cell-free translation system, it has been
demonstrated that oligosaccharide transfer occurs only when
12–14 amino acids downstream to a sequon have been trans-
located (40). The efficient N-glycosylation of N5 and its ready
accessibility for Golgi enzymes, i.e. within the fully assembled
P2X1 receptor argue against a significant membrane embed-
ding of this lipophilic domain. The glycan may serve to shield a
hydrophobic surface at this locus.
Positional Effects of N-Glycans on Surface Expression of
P2X1 Receptor Protein—The most proximal glycan (N1) ap-
pears to be especially important for high surface expression
levels of functional P2X1 receptors, whereas N2 and N5 are
dispensable in this respect. The surprising observation that the
expression level of functional receptors increased upon elimi-
nation of N3 may be correlated with an increased number of
P2X1 receptors at the plasma membrane, as evident from most
though not all surface radioiodination experiments (results not
shown), rather than by altered receptor function. The mecha-
nism of this increase is not clear yet. The peculiar role of the
glycan at N3 for ATP potency is discussed below.
If the modulatory roles of individual N-glycans are neglected,
it becomes obvious that the elimination of two of the four
canonical N-glycosylation sites per subunit is quite well toler-
ated. This suggests that the number of N-glycans per P2X1
subunit is redundant, at least for robust expression. A large
decline of the expression level occurs only after elimination of
three sites per subunit both in terms of maximum current
amplitudes and receptor protein at the cell surface. Taking the
trimeric architecture of P2X receptors into account, this means
that a total of six N-glycans are required per receptor complex
for robust functional expression. A reduction of surface appear-
ance has been observed for the nonglycosylated forms of a large
variety of glycoproteins, but the mechanisms that account for
this phenomenon appear to be different. Many nonglycosylated
forms of glycoproteins accumulate in the ER, aggregate, and do
not exit (41). Others exit the ER, but are retained in the Golgi
apparatus, apparently because N-linked oligosaccharides are
required for efficient transport from the Golgi apparatus to the
cell surface (42). Since nonglycosylated His-P2X1 receptor sub-
units or complexes accumulate neither in the ER nor in the
Golgi apparatus, rapid degradation soon after synthesis is
likely to account for the low functional expression levels and
low amounts of receptor protein at the cell surface of mutants
carrying solely one N-glycan.
Elimination of all four glycosyl acceptor sites abolished the
appearance of His-P2X1 at the cell surface. An essential role of
N-glycans has been also described for the formation of func-
tional P2X2 receptors in HEK293 cells (43). This raises the
possibility that interaction with lectin-like chaperones such as
calnexin and/or calreticulin (23) is crucial at certain stages of
the folding process and for oligomerization of P2X subunits, for
instance by providing additional time to allow for productive
collisions between P2X monomers. Incompletely folded mono-
mers that lack N-glycans as functional tags may no longer be
retained in the ER and eventually get degraded (44).
Conservation of N-Glycosylation Sites among P2X Isoforms—
The four N-glycans of P2X1 are distributed over two-thirds of
the ectodomain like the ten cysteine residues that are assumed
to be involved in disulfide formation (Fig. 1). In contrast to the
cysteines, however, which are totally conserved among all P2X
isoforms, only P2X3 exhibits a N-glycan distribution that over-
laps exactly with that of P2X1. Sequons corresponding to N1
and N2 of P2X1 are present on almost all isoforms, whereas the
sequon corresponding to N5 (Asn300) is found on P2X1-P2X3
only. The number of N-glycosylation sites likely to be used
amount to three (P2X2, P2X5, P2X6), four (P2X1, P2X3), six
(P2X7) and seven (P2X4), i.e. all isoforms carry at least three
N-glycans. Since only two such sites are actually required for
robust receptor formation, and no particular N-glycan is abso-
lutely important, variation in acceptable positions of glycans
can occur. Hence, the redundancy in the number of N-glycans
provides at least a partial explanation for the imperfect con-
servation of the number and positions of N-glycans among the
P2X isoforms.
N-Glycans and Ligand Recognition—Elimination of N-gly-
cans has only occasionally been observed to be associated with
altered ligand recognition. Lack of N-glycosylation of the glu-
cose transporter GLUT1 decreased its apparent affinity for
glucose (45). In contrast, the nonglycosylated transporter for
serotonin (46) or norepinephrine (47), like the Na1/glucose
symporter SGLT1 (48), exhibited no alteration of substrate
recognition. Elimination of the four N-glycosylation sites of the
insulin receptor b subunit also did not affect the affinity for
insulin, but blocked signal transduction (49). The single N-
glycan of the human T-cell surface glycoprotein CD2 was first
suggested by cell adhesion assays to be required for binding of
the counter receptor CD58. However, structure resolution by
NMR revealed that this N-glycan is not directly involved in
ligand binding, but crucial for the stabilization of the folded
protein structure (50). Presence of a glycan in the vicinity of the
a-bungarotoxin binding surface has been demonstrated to con-
fer a-bungarotoxin resistance to the nicotinic acetylcholine re-
ceptor (51). Most likely, the bulky glycan moiety imposes steric
hindrance for toxin binding. Referred to the present work, one
would expect a gain of function, i.e. an increase in ATP potency,
once a bulky N-glycan is removed in the vicinity of the ligand
binding site. The observation of a decrease in the potency for
ATP, i.e. a loss of function, makes it more likely that the glycan
at Asn210 imposes structural alterations, which may act to
stabilize a folded domain essential for ATP binding. A contri-
bution of this region to the ATP binding site can be inferred
from the recent observation that neutralization of the con-
served residues Lys190 and Lys215 by alanine substitution pro-
duced also a slight (2–5-fold) decrease of ATP potency (52).
FIG. 6. Position of complex-glycosylated N-glycan of P2X1 relative to a postulated reentry loop. Amino acid alignment of rat P2X1 and
P2X2, including sequon N
300GT of P2X1 (highlighted in black) and the putative second transmembrane domain (M2, highlighted in gray). The
present study demonstrates that N300GT is used as a glycosyl acceptor site and is the only one out of a total of four N-glycans that acquires
complex-type carbohydrates. The lipophilic sequence AYGIRIDVIVHGQA of rat P2X2 that has been suggested to form a reentry loop (2) and the
corresponding sequence of rat P2X1 are boxed.
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